Key Questions Answered
Q: When can early signs of multiple sclerosis show up?
A: Research indicates that patients began showing increased healthcare utilization relating to MS symptoms up to 15 years before they received an official diagnosis.
Q: What early signs do individuals with MS report?
A: Common initial symptoms included fatigue, pain, dizziness, anxiety, and depression, appearing years prior to neurological indicators.
Q: Why is this research significant?
A: It challenges the conventional timelines for MS diagnosis, paving the way for earlier detection and intervention approaches.
Summary
A comprehensive examination of health records indicates that subtle indications of multiple sclerosis (MS) could surface over ten years ahead of a formal diagnosis. Individuals who eventually developed MS showed an uptick in healthcare visits for general symptoms, such as fatigue and pain, 15 years before neurologists identified any significant neurological events.
This suggests a prolonged prodromal phase for MS, reminiscent of early-stage Parkinson’s disease, where vague symptoms precede those that are more widely recognized. Catching these earlier signs could enable proactive support, monitoring, and even strategies for prevention in the future.
Key Facts
- Long Prodrome: Healthcare usage showed a steady rise over the 15 years prior to an MS diagnosis.
- Early Indicators: Fatigue, dizziness, mental health concerns, and visual issues were among the earliest signs.
- Clinical Shift: Findings contest the assumption that MS only begins with obvious neurological symptoms.
Research from the University of British Columbia suggests that initial warning signs of multiple sclerosis may not become apparent until well after the condition begins.
In a study published in JAMA Network Open, health records of over 12,000 British Columbia residents were analyzed, revealing that those who would eventually develop MS began utilizing healthcare services at higher rates 15 years prior to exhibiting the first symptoms of the disease.
The results challenge established notions regarding when MS truly originates and provide a more detailed view of the ways patients engage with various healthcare providers during the years leading up to a diagnosis, often while seeking help for poorly defined medical problems.
“MS can be tough to identify because many of the earliest signs—like fatigue, headaches, and mental health issues—are quite general and can often be confused with other ailments,” noted Dr. Helen Tremlett, a neurology professor at UBC. “Our results significantly alter the perceived timeline for these early warning signs, possibly allowing for earlier detection and intervention.”
The study utilized integrated clinical and administrative health data to monitor physician visits over a span of 25 years leading up to the emergence of a patient’s MS symptoms, as identified by a neurologist through thorough medical evaluation.
This analysis is the first to delve so far back into patient healthcare histories. Previous studies mainly looked at trends in the five to ten years before a patient’s first demyelinating event, which is a much later marker in comparison to the neurologist-determined symptom onset date.
When compared to the general population, individuals with MS displayed a gradual increase in healthcare visits over 15 years, with specific types of doctor engagements rising at different periods:
• 15 years prior to symptom onset: Visits to general practitioners and other physicians for symptoms such as fatigue, pain, and mental health conditions, including anxiety and depression, increased significantly.
• 12 years prior: There was a rise in consultations with psychiatrists.
• 8 to 9 years prior: More visits to neurologists and ophthalmologists occurred, often linked to issues like blurred vision or eye discomfort.
• 3 to 5 years prior: Increased visits to emergency medicine and radiology occurred.
• 1 year prior: A peak in physician consultations spanned various specialties, including neurology and emergency medicine.
“These patterns hint that MS has an extended and intricate prodromal phase—where underlying changes occur before MS makes itself known,” remarked Dr. Marta Ruiz-Algueró, a postdoctoral fellow at UBC and lead author of the study.
“We’re just beginning to uncover what these early warning signals are, with mental health-related problems appearing to be among the first indicators.”
This research builds on prior work by Dr. Tremlett and her team, aiming to characterize the early stages of MS, which entail subtle symptoms that precede the hallmark signs associated with the condition.
Prodromal phases are documented in other neurological diseases as well, such as Parkinson’s, where mood fluctuations, sleep issues, and gastrointestinal problems can occur years in advance of more recognizable motor symptoms.
While the researchers point out that most individuals experiencing general symptoms will not go on to develop MS, identifying and understanding the MS prodrome could ultimately lead to quicker diagnoses and better patient outcomes.
“Recognizing these early red flags could allow for earlier intervention—whether through monitoring, support, or preventive measures,” Dr. Tremlett added. “It opens new pathways for research into early markers, lifestyle choices, and other potential triggers that might play a role during this previously neglected phase of the condition.”
